Zhitong Finance App News, Shanghai Pharmaceutical (02607.HK) announced that recently, Shanghai Hefeng Pharmaceutical Co., Ltd. (hereinafter referred to as “Shangyao Hefeng”) received the “Drug Supplement Application Approval Notice” (Notice Number: 2026B05944) issued by the State Drug Administration for lincomycin hydrochloride injections. The drug passed the generic drug consistency evaluation.

Zhitong Finance App News, Shanghai Pharmaceutical (02607.HK) announced that recently, Shanghai Hefeng Pharmaceutical Co., Ltd. (hereinafter referred to as “Shangyao Hefeng”) received the “Drug Supplement Application Approval Notice” (Notice Number: 2026B05944) issued by the State Drug Administration for lincomycin hydrochloride injections. The drug passed the generic drug consistency evaluation.